awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26853686-52A1C4BC-4853-4B90-83F0-4CB25922A1AD
Q26853686-52A1C4BC-4853-4B90-83F0-4CB25922A1AD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26853686-52A1C4BC-4853-4B90-83F0-4CB25922A1AD
Targeting BCL2-Proteins for the Treatment of Solid Tumours
P2860
Q26853686-52A1C4BC-4853-4B90-83F0-4CB25922A1AD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26853686-52A1C4BC-4853-4B90-83F0-4CB25922A1AD
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
37c62fb8806542db006f8cde35ec73995ce6c68e
P2860
Phase I study of Navitoclax (ABT-263), a novel Bcl-2 family inhibitor, in patients with small-cell lung cancer and other solid tumors.